CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.
CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.
复制标题
葡萄牙两个地区产生 CTX-M-15、OXA-30 和 TEM-1 的大肠杆菌。
DOI：
10.1093/jac/dkl062
复制
发表时间：
2006
期刊：
影响因子：
--
通讯作者：
M. Caniça
中科院分区：
文献类型：
--
作者：
N. Mendonça;D. Louro;A. P. Castro;J. Diogo;M. Caniça
1.斯宾塞RC。替莫西林J AntimicrobChemother 1990; 26：735 - 7. 2. Potz N，Hope R，Warner M等，产CTX-M的大肠杆菌现在是伦敦和英格兰东南部主要的头孢菌素耐药肠杆菌科。见：第十五届欧洲临床微生物学和传染病大会摘要，哥本哈根，丹麦，2005年。抽象O-206.临床微生物感染2005; 11增刊2：48。3. Andrews JM. BSAC标准化光盘敏感性测试方法（版本4）。J AntimicrobChemother 2005; 56：60 - 76. 4.利弗莫尔DM，温斯坦利TG，香农KP。解释性阅读：从耐药表型中识别异常并推断耐药机制。J AntimicrobChemother 2001; 48：87 - 102. 5. Woodford N，Fagan EJ，Ellington MJ.多重PCR快速检测CTX-M超广谱β-内酰胺酶基因J AntimicrobChemother 2006; 57：154 - 5. 6. Perez-Perez FJ，Hanson ND.多重PCR检测临床分离菌质粒介导AmpC酶基因临床微生物学杂志2002; 40：2153 - 62. 7. Woodford N，Ward ME，Kaufmann ME et al.英国产CTX-M超广谱β-内酰胺酶大肠杆菌的社区和医院传播。J AntimicrobChemother 2004; 54：735 - 43. 8. Frankard J，Byl B，Rodriguez-Villalobos H等人，多重耐药产气肠杆菌感染的临床表现和结局：116例病例的回顾。见：第十四届欧洲临床微生物学和传染病大会摘要，布拉格，捷克共和国，2004年。摘要P-1358.临床微生物感染2004; 10增刊3：379。9. Slocombe B，Basker MJ，Bentley PH et al. BRL 17421，一种新型b-内酰胺抗生素，对b-内酰胺酶具有高度耐药性，在人体中产生高水平和长期血清水平。抗微生物剂Chemother 1981; 20：38 - 46.
1. Spencer RC. Temocillin. J Antimicrob Chemother 1990; 26: 735–7. 2. Potz N, Hope R, Warner M et al. CTX-M-producing Escherichia coli now the dominant cephalosporin-resistant Enterobacteriaceae in London and SE England. In: Abstracts of the Fifteenth European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark, 2005. Abstract O-206. Clin Microbiol Infect 2005; 11 Suppl 2: 48. 3. Andrews JM. BSAC standardized disc susceptibility testing method (version 4). J Antimicrob Chemother 2005; 56: 60–76. 4. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognising the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 2001; 48: 87–102. 5. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum b-lactamases. J Antimicrob Chemother 2006; 57: 154–5. 6. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153–62. 7. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum b-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735–43. 8. Frankard J, Byl B, Rodriguez-Villalobos H et al. Clinical presentation and outcome of multi-resistant Enterobacter aerogenes infections: a review of 116 episodes. In: Abstracts of the Fourteenth European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, 2004. Abstract P-1358. Clin Microbiol Infect 2004; 10 Suppl 3: 379. 9. Slocombe B, Basker MJ, Bentley PH et al. BRL 17421, a novel b-lactam antibiotic, highly resistant to b-lactamases, giving high and prolonged serum levels in humans. Antimicrob Agents Chemother 1981; 20: 38–46.